New hope for slow-growing lymphoma: drug targets cancer cells before symptoms appear
NCT ID NCT03282396
First seen Oct 31, 2025 · Last updated Jun 06, 2026 · Updated 33 times
Summary
This study tests a drug called ibrutinib in 20 people with a slow-growing type of lymphoma that hasn't been treated yet. The goal is to see if the drug can stop the cancer from getting worse by blocking certain enzymes cancer cells need to grow. Participants must have no symptoms and be at high risk for progression.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MANTLE CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.